Dr Nick Samaras is CEO of MuriGen Therapeutics.
		Nick has over 20 years’ experience in the global life sciences industry and holds a PhD from the Walter & Eliza Hall Institute of Medical Research, University of Melbourne.  He is also Chairman of Replikun Biotech Ltd., Teeleostin Ltd and Q-Gen Pty Ltd. and a member of the NHMRC Research Committee.